# Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia

> **NCT00004056** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 35 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** asparaginase
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** melphalan
- **DRUG:** thioguanine
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00004056
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2002-10
- **Final completion:** 2007-03
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004056, "Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*